Tyrosine Kinase
Receptor tyrosine kinases bind to extracellular ligands/growth factors, which promotes receptor dimerization and autophosphorylation of receptor tyrosine residues. This triggers a cascade of downstream events through phosphorylation of intracellular proteins that ultimately transduce the extracellular signal to the nucleus, causing changes in gene expression. Receptor tyrosine kinases include EGFR/ErbB, PDGFR, VEGFR, FGFR and MET subfamilies etc. Dysfunctions in tyrosine phosphorylation are linked to oncogenic transformation. In additions, various adaptor and effector proteins couple to carboxy-terminal of an active kinase. For instance, binding of the GRB2 adaptor protein activates EGFR and MAPK/ERK signaling.
Non-receptor tyrosine kinases involve many well-defined proteins (e.g. the Src family kinases, c-Abl, and Jak kinases) and other kinases which regulates cell growth and differentiation. For example, Src family kinases are curial for activating and inhibitory pathways in the innate immune response.
- A8706 BLU9931Target: FGFRSummary: FGFR4 inhibitor,potent and irreversible
- B5843 CTX0294885Target: KinasesSummary: Pan-kinase inhibitor
- B6054 EAI045Summary: Inhibitor of L858R/T790M EGFR mutants
- A4475 TLQP 21Summary: VGF-derived peptide
- A4513 Lestaurtinib1 CitationSummary: JAK2/FLT3/TrkA inhibitor
- A3967 Lapatinib DitosylateTarget: EGFR|ErbB-2Summary: EGFR/HER2 inhibitor,potent and selective
- A3969 Vatalanib1 CitationTarget: VEGFRSummary: VEGFR-1/-2 inhibitor,cell-permeable
- A8218 Lapatinib2 CitationTarget: ErbBSummary: EGFR/HER2 inhibitor,potent,selective and reversible
- A8219 Gefitinib (ZD1839)3 CitationTarget: EGFRSummary: Selective EGFR inhibitor
- A8232 Nilotinib(AMN-107)1 CitationTarget: Bcr-AblSummary: Bcr-Abl kinase inhibitor,selective